Literature DB >> 9405950

Low prevalence of active parvovirus B19 infection in HIV-infected patients.

G Raguin1, M Leruez-Ville, V Gregoire, M Deplanche, C Leport, F Morinet, J L Vilde.   

Abstract

In a prospective study to determine the prevalence of parvovirus B19 in adult patients positive for the human immunodeficiency virus, a series of 55 consecutively presenting patients was tested for antibodies to parvovirus B19 and parvovirus B19 DNA. Specific IgG antibodies were detected in 96% of cases; specific IgM antibodies were present in 10%. Viral DNA was not detected in any of the sera analysed by polymerase chain reaction. Anemia could not be correlated with the presence of either IgG or IgM antibodies to parvovirus B19. Thus, no evidence of acute or chronic parvovirus B19 infection was found in the 55 patients. These findings suggest that active parvovirus B19 infection is uncommon in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405950     DOI: 10.1007/bf01709261

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

Review 1.  Parvovirus B19 and human disease.

Authors:  T J Török
Journal:  Adv Intern Med       Date:  1992

2.  Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera.

Authors:  F Morinet; L D'Auriol; J D Tratschin; F Galibert
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

3.  Chronic bone marrow failure due to persistent B19 parvovirus infection.

Authors:  G J Kurtzman; K Ozawa; B Cohen; G Hanson; R Oseas; N S Young
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

4.  Parvovirus infection and the acquired immunodeficiency syndrome.

Authors:  M J Anderson; I M Kidd; S E Jones; J R Pattison; M H Grieco; M Lange; E Buimovici-Klein; L Z Cooper
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

5.  Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.

Authors:  J J Gray; B J Cohen; U Desselberger
Journal:  J Virol Methods       Date:  1993-09       Impact factor: 2.014

6.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

7.  Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.

Authors:  E Chernak; G Dubin; D Henry; S J Naides; R L Hodinka; R R MacGregor; H M Friedman
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

8.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

9.  Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients.

Authors:  M Musiani; M Zerbini; G Gentilomi; G Rodorigo; V De Rosa; D Gibellini; S Venturoli; G Gallinella
Journal:  J Med Virol       Date:  1995-06       Impact factor: 2.327

10.  Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy.

Authors:  S J Naides; E J Howard; N S Swack; C A True; J T Stapleton
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

View more
  2 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  The human parvovirus B19/human immunodeficiency virus co-infection in healthy eligible voluntary blood donors at the Blood Transfusion National Center in Kinshasa.

Authors:  Chabo Byaene Alain; Lufimbo Katawandja Antoine; Bizeti Nsangu Bizette; Pambu Dahlia; Tshibuela Beya Dophie; Muwonga Masidi Jérémie; Kayembe Nzongola-Nkasu Donatien; Ahuka Mundeke Steve
Journal:  Pan Afr Med J       Date:  2020-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.